Paravalvular leak (PVL) is very common after TAVI and has been reported to have a
negative impact on both short-and long-term survival. The current study identified incidence …

Objective. Valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) has emerged as
a useful alternative intervention to redo-surgical aortic valve replacement (Redo-SVAR) for …

Abstract Background/Aim With the growing contemporary use of bioprosthetic valves, whose
limited long‐term durability has been well‐documented, an increase in the need for …

The use of valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) is increasing, but
studies evaluating clinical outcomes in these patients are scarce. Also, there are limited data …

Transcatheter aortic valve replacement (TAVR) has emerged as a ground‐breaking,
minimally invasive alternative to traditional open‐heart surgery, primarily designed for …

Transcatheter aortic valve replacement has emerged as the standard treatment for the
majority of patients with symptomatic aortic stenosis. As transcatheter aortic valve …

Over the past two decades since the first transcatheter aortic valve implantation (TAVI) was
performed, substantial changes to technique, technology and indications have taken place …

Objective We sought to investigate real-world outcomes of patients with degenerated
biological aortic valve prostheses who had undergone valve-in-valve transcatheter aortic …

As transcatheter aortic valve replacement (TAVR) expands into a younger and lower risk
cohort of patients, many important clinical questions are raised, including the one of overall …

Over the last decades, bioprosthetic heart valves (BHV) have been increasingly implanted
instead of mechanical valves in patients undergoing surgical aortic valve replacement …